baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

HSBC WAR. CALL 01/27 22UA/ DE000HS4PU54 /

2024-06-14 9:35:34 PM	Chg.-0.1000	Bid9:59:11 PM	Ask9:59:11 PM	Underlying	Strike price	Expiration date	Option type
1.2400EUR	-7.46%	1.2000 Bid Size: 150,000	1.2200 Ask Size: 150,000	BioNTech SE	150.00 USD	2027-01-15	Call

GlobeNewswire 06-01 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...

GlobeNewswire 05-29 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem

GlobeNewswire 05-28 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...

GlobeNewswire 05-21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...

GlobeNewswire 05-21 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...

GlobeNewswire 05-17 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

GlobeNewswire 05-17 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire 05-09 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

TeleTrader 05-06 BioNTech's Q1 revenue slumps 85% to €187.6M

GlobeNewswire 05-06 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update

TeleTrader 05-06 Europe mixed premarket with data on the limelight

GlobeNewswire 05-02 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 04-22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

GlobeNewswire 04-10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...

GlobeNewswire 04-07 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...

GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology

GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

TeleTrader 03-20 BioNTech Q4 revenue plunges 65% to €1.48B

GlobeNewswire 03-20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

GlobeNewswire 03-20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer

TeleTrader 03-20 Europe mixed premarket amid data

GlobeNewswire 03-14 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

GlobeNewswire 03-12 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...

GlobeNewswire 03-11 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...

HSBC WAR. CALL 01/27 22UA/ DE000HS4PU54 /

If you wish to receive reply to your feedback, please provide your email address.